WESCOE FOUNDATION FOR PULMONARY FIBROSIS (EIN 274464618) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

JENNIFER SINGLEY

Phone

4845536340

Tax Period

2023-01-01 to 2023-12-31

WESCOE FOUNDATION FOR PULMONARY FIBROSIS, founded in 2009, is a small nonprofit in the Medical Research sector that reported $196K in total revenue in fiscal year 2023. Revenue surged 28% from the prior year, signaling strong growth momentum.

Mission

THE WESCOE FOUNDATION FOR PULMONARY FIBROSIS PROVIDES SUPPORT, EDUCATION, ADVOCACY AND RESOURCES FOR PATIENTS LIVING WITH IDIOPATHIC PULMONARY FIBROSIS (IPF), THEIR FAMILIES AND CARE PARTNERS IN ORDER TO SUSTAIN THE HIGHEST POSSIBLE QUALITY OF LIFE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $207,299

Program Service Revenue $0

Investment Income $25

Other Revenue $-11,110

TOTAL REVENUE $196,214

Expense Breakdown

Grants Paid $0

Salaries & Benefits $93,671

Fundraising Expenses $36,057

Program Expenses $99,516

Other Expenses $103,120

TOTAL EXPENSES $196,791

Year-over-Year Comparison

	2023	2022	Change
Revenue	$196,214	$153,735	+0.3%
Expenses	$196,791	$276,947	-0.3%
Net Income	$-577	$-123,212	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$45,000

Total Directors

$45,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JENNIFER WESCOE SINGLEY	EXECUTIVE DIRECTOR	50.00	Officer Director	$45,000	$0	$45,000
TRISHA COLASURDO	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
JENNIFER FERNANDES FORMER	SECRETARY	1.00	Officer Director	$0	$0	$0
GERARD PETERSEN	PRESIDENT	1.00	Officer Director	$0	$0	$0
KYLE ELSENBAUMER	TREASURER	1.00	Officer Director	$0	$0	$0
MIKE PFEIFFER	BOARD MEMBER	1.00	Director	$0	$0	$0
DOUGLAS CORWIN	BOARD MEMBER	1.00	Director	$0	$0	$0
DENNIS MCGORRY	BOARD MEMBER	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$196,214	$196,791	$15,327	$-577
2022	$153,735	$276,947	$15,904	$-123,212
2021	$168,651	$166,408	$139,116	$2,243
2020	$199,569	$87,131	$136,873	$112,438

WESCOE FOUNDATION FOR PULMONARY FIBROSIS